Or­biMed leads $70M raise for Har­poon Ther­a­peu­tics; Zio­pharm inks com­bo deal with Re­gen­eron's PD-1

→ Or­biMed has led the syn­di­cate for a $70 mil­lion Se­ries C round for Har­poon Ther­a­peu­tics. The new mon­ey will be put to use on the South San Fran­cis­co biotech’s plat­form tech in­volv­ing T cell en­gagers. New in­vestors Cor­morant, Ridge­back Cap­i­tal In­vest­ments, Lil­ly Asia Ven­tures and NS In­vest­ment al­so jumped in along­side ex­ist­ing in­vestors MPM Cap­i­tal, On­col­o­gy Im­pact Fund, Ar­ix Bio­science, New Leaf Ven­ture Part­ners and Tai­ho Ven­tures

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER